Kazia Therapeutics : Annual Report (SEC Filing - 20-F) : com

Form 20-F

Table of Contents



Table of Contents



UNITED STATES


SECURITIES AND EXCHANGE COMMISSION
... | October 7, 2021

Related Keywords

New York , United States , Australia , Taiwan , Memorial Sloan Kettering Cancer Center , Japan , Hong Kong , District Of Columbia , United Kingdom , Washington , Boston , Massachusetts , China , California , Kate Hill , Western Australia , Austria , Germany , Seoul , Soult Ukpyolsi , South Korea , New Zealand , Sydney , New South Wales , Dana Farber Cancer Institute , Singapore , Sweden , France , South Wales , Macau , Commonwealth Of Australia , America , Australian , Swedish , Chinese , Austrian , American , Jose Pablo Leone , Gabrielle Heaton , Iain Ross , Bryce Carmine , Lakshmi Nayak , Eli Lilly , Watkins Coffey Martin , James Garner , Paul Hopper , Lew Cantley , T Jonathan Yang , Steven Coffey , University Of Technology , Analysis Centre , Revenue Service , Peer Review Committee , Kazia Laboratories Pty Ltd , Kazia Therapeutics Limited , Id Exchange , University Of Queensland , Foreign Investment Company , Glioblast Pty , International Towers Level , Meeting Of The Company , Hishenk Pty , Society For Neuro , Global Pharmaceutical Product Development , European Union Regulatory Requirements , United States Is Vcorp Services , Celltech Group Plc , Kazia National Market Listing Application , Company Employee Share Option Plan , Kazia Therapeutics , Risk Committee , Institute Of Chartered Accountants , Weill Cornell Cancer Centre , Articles Of Association , Elmo Software Limited , Remuneration Committee , Company Share Purchase Plan , Biomer Technology , Platinum International Healthcare Fund , Reneuron Group , Company Executive Committee , Roche Group , Oncoceutics Inc , Company Adss , Simcere Pharmaceutical Group , Grant Thornton Audit Pty Ltd , Oncology Consortium , Australian Securities Exchange , Haemalogix Pty Ltd , Group Executives , Company Constitution , Kazia Therapeutics Hong Kong , Key Management Personnel Of The Company , Party Transactions , Deloitte Touche Tohmatsu , Acquisition Of Glioblast Pty Ltd , Australian Institute Of Company Directors , Company Directors , Chimerix Inc , Simcere Pharmaceutical Group Ltd , Genentech Inc , St Jude Children Research Hospital In Memphis , Hunter Medical Research Institute In Newcastle , Contract Research Organisations Cros , Company Ordinary , Glioblast Pty Ltd , Genentech Inc South San Francisco , Public Health Service , European Medicines Agency , Bain Company , Global Coalition For Adaptive Research , Company Contact Person , Nasdaq , Palla Pharma Limited , Australian Government Department Of Foreign Affairs , Nomination Committee , American Association For Cancer Research Annual Meeting , Australian Taxation Office , Product Development , Kazia Therapeutics Inc , Quest Asset Partners Pty Ltd , International Towers , Owners Of Kazia Therapeutics , Services Tax , Audit Committee Financial Expert , Committee For Medicinal Products Human Use , Corporate Governance Of Kazia Therapeutics , Shareholders Holding Shares On Revenue , International Non , Drug Administration , European Commission , Australian Takeover Panel , Board Of Kazia , Kazia Research Pty Ltd , Exchange Commission , Stock Market , Investments Commission , Many Of The Company , Securities Exchange , Countplus Limited , Us Securities Exchange , Committee Of The Board , Genentech , Eli Lilly Co , Audit Committee , Machines Limited , Company Annual Report On Form , Holding Tax , International Accounting Standards Board , Double Taxation Convention , International Financial Reporting Standards , Governance Committee , Good Laboratory Practices , Alliance For Clinical Trials In Oncology , Audit Committee Charter , Ac Research , Advisory Committee On Prescriptive Medicines , Therapeutic Goods Administration , Fisons Plc , Mark One , Depositary Shares , American Depositary , Ordinary Shares , Securities Exchange Act , Interactive Data File , Exchange Act , Sarbanes Oxley Act , Financial Reporting Standards , Senior Management , Expected Timetable , Financial Review , Related Party Transactions , Qualitative Disclosures , Market Risk , Equity Securities , Dividend Arrearages , Security Holders , Accounting Fees , Listing Standards , Audit Committees , Affiliated Purchasers , Certifying Accountant , Annual Report , Private Securities Litigation Reform Act , Securities Act , Financial Condition , Capital Requirement , Business Operations , Contract Research Organisations , Regulatory Approval , Product Candidates , Orphan Drug Act , Intellectual Property , Third Parties , Australian Corporations Act , American Depositary Shares , United States Federal Income Tax , Corporations Act , Therapeutics Limited , Three International Towers , Vcorp Services ,